Search results
US Fentanyl Seizures Skyrocket
Medscape· 6 days agoFentanyl seizures in the US increased by 1700% between 2017 and 2023, a new report showed.
Small Business - Cordele Dispatch | Cordele Dispatch
Cordele Dispatch· 6 days agoFDA Roundup: May 21, 2024 PR Newswire SILVER SPRING, Md., May 21, 2024 SILVER SPRING, Md., May 21, 2024 /PRNewswire/ -- Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: Today, the
Portal Use Low Among Minorities, Non-English Speakers
Medscape· 6 days agoClinicians may need to communicate with these patients using means other than patient portals to...
Model Guides Poststroke Seizure Risk and Driving Decisions
Medscape· 4 days agoEstimating the risk for unprovoked seizures in the year following an ischemic stroke with the SeLECT...
Low-FODMAP, Low-Carb Diets May Beat Medical Tx for IBS
Medscape· 7 days agoDietary interventions could be considered as an initial treatment for patients with IBS, although...
Exploring PAs' Hesitance to Use Mental Health Provider Plans
Medscape· 7 days agoDuring her training as a physician associate (PA), Stephanie Neary, MPA, MMS, PA-C, assistant...
UPFs an Independent Risk Factor for Poor Brain Health
Medscape· 5 days agoConsuming highly processed foods may be harmful to the aging brain, independent of other risk...
Guidelines on Rapid BP Reduction in Stroke Challenged
Medscape· 6 days agoNew findings challenge the practice of rapidly lowering blood pressure (BP) in acute ischemic stroke...
Bristol Myers Squibb to Present Data at the 2024 American Society of Clinical Psychopharmacology...
Morningstar· 5 days agoBristol Myers Squibb to Present Data at the 2024 American Society of Clinical Psychopharmacology Annual Meeting Consistent with short-term studies, KarXT was not associated with clinically meaningful changes in movement disorder scale scores and a
Oncolytics Biotech® ASCO Abstracts Highlight Pelareorep's Potential in Pancreatic Cancer and...
FOX 23 News Albany· 4 days agoOncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy for oncology, presented two abstracts at the 2024 American Society of Clinical ...